Glycopeptide-Intermediate Staphylococcus aureus: Evaluation of a Novel Screening Method and Results of a Survey of Selected U.S. Hospitals

Isolates of Staphylococcus aureus with decreased susceptibilities to glycopeptide antimicrobial agents, such as vancomycin and teicoplanin, have emerged in the United States and elsewhere. Commercially prepared brain heart infusion agar (BHIA) supplemented with 6 μg of vancomycin per ml was shown in...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Microbiol
Principais autores:	Hubert, Susannah K., Mohammed, Jasmine M., Fridkin, Scott K., Gaynes, Robert P., McGowan, John E., Tenover, Fred C.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Bacteriology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC85700/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10523558/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.37.11.3590-3593.1999
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!